谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Clinicopathological and Prognostic Features of HER2-null and HER2-low Advanced Breast Cancer Treated with Eribulin or Capecitabine.

Rui Kitadai,Tatsunori Shimoi,Shu Yazaki,Hitomi Sumiyoshi Okuma, Mai Hoshino,Munehiro Ito,Ayumi Saito,Shosuke Kita,Yuki Kojima,Tadaaki Nishikawa,Kazuki Sudo,Emi Noguchi, Yasuhiro Fujiwara,Masayuki Yoshida,Kan Yonemori

BREAST CANCER（2024）

引用 0|浏览4
暂无评分
关键词
HER2-low,Advanced breast cancer,Eribulin,Capecitabine,Overall survival
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要